CRISPR/Cas Gene-Editing Technique Holds Great Promise, but Research Moratorium Makes Sense Pending Further Study
By Jeff Bessen,
The Conversation
| 07. 29. 2015
Untitled Document
CRISPR/Cas is a new technology that allows unprecedented control over the DNA code. It’s sparked a revolution in the fields of genetics and cell biology, becoming the scientific equivalent of a household name by raising hopes about new ways to cure diseases including cancer and to unlock the remaining mysteries of our cells.
The gene editing technique also raises concerns. Could the new tools allow parents to order “designer babies”? Could premature use in patients lead to unforeseen and potentially dangerous consequences? This potential for abuse or misuse led prominent scientists to call for a halt on some types of new research until ethical issues can be discussed – a voluntary ban that was swiftly ignored in some quarters.
The moratorium is a positive step toward preserving the public’s trust and safety, while the promising new technology can be further studied.
Editing DNA to cure disease
While most human diseases are caused, at least partially, by mutations in our DNA, current therapies treat the symptoms of these mutations but not the genetic root cause. For example, cystic fibrosis...
Related Articles
By Adithi Ramakrishnan, AP News | 08.05.2026
NEW YORK (AP) — Matt Walker couldn’t pet a dog without sneezing — until he and other scientists used a gene editing technique to produce a hypoallergenic beagle named Bailey.
Now, he can feed Bailey spoons of peanut butter while...
By Edward Chen, Nature | 07.28.2026
A small number of fertility clinics around the world are offering a controversial treatment: a procedure to furnish clients’ embryos with donated mitochondria as a way to increase the chances of taking home a baby.
The method, called mitochondrial replacement...
By Gina Kolata , The New York Times | 07.21.2026
Without fail, David Liu of the Broad Institute gets at least 20 messages every week from desperate parents. Their child, they’ll explain, has an ultrarare and devastating disorder caused by a mutant gene. Can he help them develop a gene...
By Matthew Herper, Stat | 07.01.2026
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...